Skip to main content
. 2025 Oct 24;14(11):1072. doi: 10.3390/antibiotics14111072
AMR Antimicrobial resistance
CBA Cost–benefit analysis
CEA Cost-effectiveness analysis
CMA Cost minimization analysis
COI Cost of illness
CUA Cost–utility analysis
DALYs Disability-Adjusted Life Years
DHSC Department of Health and Social Care
HICs High-income countries
Lao PDR Lao People’s Democratic Republic
LICs Low-income countries
LMICs Lower- and middle-income countries
MeSH Medical subject headings
MMAT Mixed-methods appraisal tool
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
QALYs Quality-adjusted life years
UK United Kingdom
USA United States of America
WB World Bank
WHO World Health Organization